Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.

Serum adenosine deaminase (ADA) activity increases in diseases where cellular immunity is involved. Since cell-mediated immune responses play a paramount role in the pathogenesis and healing of the visceral leishmaniasis, therefore, the present study was undertaken to evaluate the serum ADA activity...

Full description

Bibliographic Details
Main Authors: Vijayamahantesh, Ajay Amit, Manas R Dikhit, Raj K Pandey, Kuljit Singh, Ritesh Mishra, V N R Das, Pradeep Das, Sanjiva Bimal
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4871472?pdf=render
_version_ 1819118633821929472
author Vijayamahantesh
Ajay Amit
Manas R Dikhit
Raj K Pandey
Kuljit Singh
Ritesh Mishra
V N R Das
Pradeep Das
Sanjiva Bimal
author_facet Vijayamahantesh
Ajay Amit
Manas R Dikhit
Raj K Pandey
Kuljit Singh
Ritesh Mishra
V N R Das
Pradeep Das
Sanjiva Bimal
author_sort Vijayamahantesh
collection DOAJ
description Serum adenosine deaminase (ADA) activity increases in diseases where cellular immunity is involved. Since cell-mediated immune responses play a paramount role in the pathogenesis and healing of the visceral leishmaniasis, therefore, the present study was undertaken to evaluate the serum ADA activity in different pathological conditions. Adenosine deaminase was determined in sera of active visceral leishmaniasis (VL) patients (n = 39), active postkala-azar dermal leishmaniasis (PKDL) cases (n = 34) at the point of diagnosis and after treatment stages along with healthy controls (n = 30), endemic healthy subjects (n = 34) and endemic asymptomatic subjects (n = 34).Our in-vitro result revealed that monocytes secrete significant ADA level in response to Leishmania donovani (L.donovani) stimulation. The serum ADA activity in active VL and PKDL subjects were found to be significantly higher than that of respective treated cases and healthy controls. We also observed a marginal number (17.6%) of endemic asymptomatic subjects showed elevated serum ADA activity. Further, the ADA activity in PKDL was found to be decreased gradually during the different phases of treatment. Interestingly, 2 out of 32 treated VL cases found to have high serum ADA activity during follow up period were relapsed within few days. These results suggest the possibility of ADA as a marker of clinical pathogenesis and can be used as a surrogate marker in the diagnosis and prognosis of VL and PKDL.
first_indexed 2024-12-22T05:51:59Z
format Article
id doaj.art-c273b3f514f842999410047fc09dc8b3
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-22T05:51:59Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c273b3f514f842999410047fc09dc8b32022-12-21T18:36:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01115e015411710.1371/journal.pone.0154117Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.VijayamahanteshAjay AmitManas R DikhitRaj K PandeyKuljit SinghRitesh MishraV N R DasPradeep DasSanjiva BimalSerum adenosine deaminase (ADA) activity increases in diseases where cellular immunity is involved. Since cell-mediated immune responses play a paramount role in the pathogenesis and healing of the visceral leishmaniasis, therefore, the present study was undertaken to evaluate the serum ADA activity in different pathological conditions. Adenosine deaminase was determined in sera of active visceral leishmaniasis (VL) patients (n = 39), active postkala-azar dermal leishmaniasis (PKDL) cases (n = 34) at the point of diagnosis and after treatment stages along with healthy controls (n = 30), endemic healthy subjects (n = 34) and endemic asymptomatic subjects (n = 34).Our in-vitro result revealed that monocytes secrete significant ADA level in response to Leishmania donovani (L.donovani) stimulation. The serum ADA activity in active VL and PKDL subjects were found to be significantly higher than that of respective treated cases and healthy controls. We also observed a marginal number (17.6%) of endemic asymptomatic subjects showed elevated serum ADA activity. Further, the ADA activity in PKDL was found to be decreased gradually during the different phases of treatment. Interestingly, 2 out of 32 treated VL cases found to have high serum ADA activity during follow up period were relapsed within few days. These results suggest the possibility of ADA as a marker of clinical pathogenesis and can be used as a surrogate marker in the diagnosis and prognosis of VL and PKDL.http://europepmc.org/articles/PMC4871472?pdf=render
spellingShingle Vijayamahantesh
Ajay Amit
Manas R Dikhit
Raj K Pandey
Kuljit Singh
Ritesh Mishra
V N R Das
Pradeep Das
Sanjiva Bimal
Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.
PLoS ONE
title Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.
title_full Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.
title_fullStr Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.
title_full_unstemmed Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.
title_short Elevated Serum ADA Activity as a Marker for Diagnosis and Prognosis of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis in Indian Patients.
title_sort elevated serum ada activity as a marker for diagnosis and prognosis of visceral leishmaniasis and post kala azar dermal leishmaniasis in indian patients
url http://europepmc.org/articles/PMC4871472?pdf=render
work_keys_str_mv AT vijayamahantesh elevatedserumadaactivityasamarkerfordiagnosisandprognosisofvisceralleishmaniasisandpostkalaazardermalleishmaniasisinindianpatients
AT ajayamit elevatedserumadaactivityasamarkerfordiagnosisandprognosisofvisceralleishmaniasisandpostkalaazardermalleishmaniasisinindianpatients
AT manasrdikhit elevatedserumadaactivityasamarkerfordiagnosisandprognosisofvisceralleishmaniasisandpostkalaazardermalleishmaniasisinindianpatients
AT rajkpandey elevatedserumadaactivityasamarkerfordiagnosisandprognosisofvisceralleishmaniasisandpostkalaazardermalleishmaniasisinindianpatients
AT kuljitsingh elevatedserumadaactivityasamarkerfordiagnosisandprognosisofvisceralleishmaniasisandpostkalaazardermalleishmaniasisinindianpatients
AT riteshmishra elevatedserumadaactivityasamarkerfordiagnosisandprognosisofvisceralleishmaniasisandpostkalaazardermalleishmaniasisinindianpatients
AT vnrdas elevatedserumadaactivityasamarkerfordiagnosisandprognosisofvisceralleishmaniasisandpostkalaazardermalleishmaniasisinindianpatients
AT pradeepdas elevatedserumadaactivityasamarkerfordiagnosisandprognosisofvisceralleishmaniasisandpostkalaazardermalleishmaniasisinindianpatients
AT sanjivabimal elevatedserumadaactivityasamarkerfordiagnosisandprognosisofvisceralleishmaniasisandpostkalaazardermalleishmaniasisinindianpatients